Related Experiment Video
Updated: Jan 13, 2026

Methyl-binding DNA capture Sequencing for Patient Tissues
Published on: October 31, 2016
PCBP1 binding to single-stranded poly-cytosine motifs enhances cGAS sensing and impairs breast cancer development
Cécile Fréreux1, Joseph A Q Karam1, Breege V Howley1
1Department of Biochemistry and Molecular Biology, Medical University of South Carolina, Charleston, SC, USA.
Abstract:
The cGAS-STING pathway plays a central role in controlling tumor progression through nucleic acid sensing and type I Interferon production. Here, we identify Poly(rC) Binding Protein 1 as a tumor suppressor that amplifies cGAS-STING signaling in breast cancer. Using patient datasets and a transgenic mouse model with conditional PCBP1 knockout in mammary epithelial cells, we show that PCBP1 expression correlates with improved survival, reduced tumor burden, increased type I Interferon and Interferon Stimulated Gene expression, and elevated cytotoxic T cell infiltration. Mechanistically, PCBP1 binds cytosine-rich single-stranded motifs via its KH domains and increases cGAS affinity to these nucleic acids. Mutation of PCBP1's conserved GXXG loops impairs nucleic acid binding and cGAS activation. Although cGAS is a double-stranded DNA sensor with no intrinsic sequence specificity, we uncover that the single-stranded nucleic-acid binding protein PCBP1 enhances cGAS sensing by engaging sequence-specific motifs, acting as a nucleic acid co-sensor that impairs tumorigenesis.
Insights
Poly(rC) Binding Protein 1 (PCBP1) acts as a tumor suppressor in breast cancer by enhancing the cGAS-STING pathway. This boosts anti-tumor immunity and improves patient survival.
Area of Science:
- Immunology
- Cancer Biology
- Molecular Biology
Background:
- The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for detecting cytosolic nucleic acids and initiating anti-tumor immune responses.
- Dysregulation of this pathway is implicated in various cancers, including breast cancer, highlighting its therapeutic potential.
Purpose of the Study:
- To investigate the role of Poly(rC) Binding Protein 1 (PCBP1) in breast cancer progression and its impact on the cGAS-STING pathway.
- To elucidate the molecular mechanisms by which PCBP1 influences nucleic acid sensing and immune activation.
Main Methods:
- Analysis of patient datasets to correlate PCBP1 expression with clinical outcomes.
- Utilizing a transgenic mouse model with conditional PCBP1 knockout in mammary epithelial cells.
- Biochemical assays to assess PCBP1's interaction with nucleic acids and its effect on cGAS activity.
Main Results:
- PCBP1 expression inversely correlates with tumor burden and is associated with improved patient survival.
- PCBP1 knockout leads to reduced type I Interferon production, decreased expression of Interferon Stimulated Genes, and diminished cytotoxic T cell infiltration.
- PCBP1 binds to cytosine-rich single-stranded motifs, enhancing cGAS binding to nucleic acids and potentiating cGAS-STING pathway activation.
Conclusions:
- PCBP1 functions as a tumor suppressor in breast cancer by amplifying cGAS-STING signaling.
- PCBP1 acts as a nucleic acid co-sensor, enhancing the specificity and efficacy of cGAS-mediated immune surveillance.
- Targeting PCBP1 or enhancing its function may represent a novel therapeutic strategy for breast cancer.
More Related Videos
Related Concept Videos
GPCRs Regulate Adenylyl Cylase Activity
Inhibition of Cdk Activity
Abnormal Proliferation
Epigenetic Regulation
Epigenetic Regulation
X-chromosome...
Cooperative Binding of Transcription Regulators

